| Integrated genomic analyses of ovarian carcinoma | Nature | 2011 | 5.2K |
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | New England Journal of Medicine | 2004 | 3.5K |
| One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States | Journal of Clinical Oncology | 2008 | 3.1K |
| The somatic genomic landscape of glioblastoma | Cell | 2013 | 2.9K |
| Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 2.8K |
| The future of immune checkpoint therapy | Science | 2015 | 2.7K |
| Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | New England Journal of Medicine | 2016 | 2.6K |
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Nature Genetics | 1997 | 2.4K |
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Cancer Cell | 2006 | 2.3K |
| Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis | Journal of Clinical Oncology | 2005 | 2.2K |
| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 | Cell Death and Differentiation | 2018 | 2.2K |
| Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy | Cell | 2017 | 2.1K |
| Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy | Journal of Clinical Oncology | 2004 | 2K |
| Lung cancer | New England Journal of Medicine | 2008 | 1.9K |
| Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers | Journal of the National Cancer Institute | 2005 | 1.9K |
| Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Journal of Clinical Oncology | 2008 | 1.9K |
| Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients | Science | 2018 | 1.9K |
| Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma | Cancer Cell | 2010 | 1.8K |
| Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer | New England Journal of Medicine | 1999 | 1.8K |
| Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer | Journal of Clinical Oncology | 2004 | 1.7K |
| Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | Nature | 2015 | 1.7K |
| Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2 | Journal of Clinical Oncology | 2004 | 1.5K |
| Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1 | Journal of Clinical Oncology | 2004 | 1.5K |
| Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma | Journal of Clinical Oncology | 2015 | 1.5K |
